Home/Filings/4/0001209191-13-002110
4//SEC Filing

DERBYSHIRE ADAM C 4

Accession 0001209191-13-002110

CIK 0001009356other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:43 PM ET

Size

7.4 KB

Accession

0001209191-13-002110

Insider Transaction Report

Form 4
Period: 2013-01-02
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
  • Tax Payment

    Common Stock

    2013-01-02$40.47/sh6,130$248,081170,471 total
Holdings
  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17Common Stock (30,000 underlying)
    30,000
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]Represents shares forfeited to the company in connection with the satisfaction of tax liabilities incurred upon the annual vesting of restricted stock, and does not involve a sale of stock in the market.
  • [F2]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeother

Related Parties

1
  • filerCIK 0001212669

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:43 PM ET
Size
7.4 KB